Explore our materials

Filters

Results (14539)

Slideset

HIV

HIV DART and Emerging Viruses 2016

Collateral Damage with Antiviral Therapy | David Thomas, MD, MPH

Scott Letendre

Slideset

HIV

HIV DART and Emerging Viruses 2016

Management of Neurocognitive Impairment of Aging Populations Living with HIV | Scott Letendre, MD

Slideset

HIV

HIV DART and Emerging Viruses 2016

(Abstract) Antiviral Activity of tenofovir alafenamide against HIV-1 with thymidine analog mutation(s) and M184V | C. Callebaut

Slideset

HIV

HIV DART and Emerging Viruses 2016

(Abstract) Development of a protease inhibitor-based single-tablet complete HIV-1 regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (DCFTAF) | B. Baugh

Mark Wainberg

Slideset

HIV

HIV DART and Emerging Viruses 2016

Gertrude Elion Distinguished Lecturer Award Lecture Stories on Scientific Discoveries that Transformed HIV into a Manageable Disease | Mark Wainberg, MD

Slideset

HIV

HIV DART and Emerging Viruses 2016

(Abstract) Anti–HIV drug candidate abx464 prevents intestinal inflammation by producing IL22 in activated macrophages | J. Tazi

Slideset

HIV

HIV DART and Emerging Viruses 2016

Current Clinical Therapies for HIV Remission | David Margolis, MD

Slideset

HIV

HIV DART and Emerging Viruses 2016

Impact of Jak Inhibitors on HIV Reservoir Maintenance, Lifespan and Expansion in Primary T Cells and Macrophages | Christina Gavegnano, PhD

Slideset

HIV

HIV DART and Emerging Viruses 2016

(Abstract) HIV-1 dynamics under integrase inhibitor therapy suggests a subset of cells with slow integration | R.M. Ribeiro

Slideset

HIV

HIV DART and Emerging Viruses 2016

(Abstract) Differential responses of memory CD4+ T cell subsets to HIV latency reversing agents | D. Kulpa

Slideset

HIV

HIV DART and Emerging Viruses 2016

David Barry DART Achievement Award Lecture: The Discovery of SIV and Development of Monkey Models for the Study of HIV/ AIDS | Ronald Desrosiers, PhD

Slideset

HIV

HIV DART and Emerging Viruses 2016

Explore our materials

Your Selection Clear All

Topic

Material Type

Event

Collateral Damage with Antiviral Therapy | David Thomas, MD, MPH

Management of Neurocognitive Impairment of Aging Populations Living with HIV | Scott Letendre, MD

(Abstract) Antiviral Activity of tenofovir alafenamide against HIV-1 with thymidine analog mutation(s) and M184V | C. Callebaut

(Abstract) Development of a protease inhibitor-based single-tablet complete HIV-1 regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (DCFTAF) | B. Baugh

Gertrude Elion Distinguished Lecturer Award Lecture Stories on Scientific Discoveries that Transformed HIV into a Manageable Disease | Mark Wainberg, MD

(Abstract) Anti–HIV drug candidate abx464 prevents intestinal inflammation by producing IL22 in activated macrophages | J. Tazi

Current Clinical Therapies for HIV Remission | David Margolis, MD

Impact of Jak Inhibitors on HIV Reservoir Maintenance, Lifespan and Expansion in Primary T Cells and Macrophages | Christina Gavegnano, PhD

(Abstract) HIV-1 dynamics under integrase inhibitor therapy suggests a subset of cells with slow integration | R.M. Ribeiro

(Abstract) Differential responses of memory CD4+ T cell subsets to HIV latency reversing agents | D. Kulpa

David Barry DART Achievement Award Lecture: The Discovery of SIV and Development of Monkey Models for the Study of HIV/ AIDS | Ronald Desrosiers, PhD

HIV-1 Macrophage Reservoirs: Lessons from Host Macrophage Specific Restriction Factor, SAMHD1 | Baek Kim, PhD